- You must be logged in to add items to the cart.
Description
Innotox® is a ready-to-use liquid botulinum toxin type A preparation for intramuscular administration in clinical aesthetics and related protocols. Clinic buyers benefit from US distribution and clear chain-of-custody support. The Innotox 50 U presentation arrives as a sterile solution that streamlines allocation at the unit level and removes on-site reconstitution from your workflow.
Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.
What Innotox Is and How It Works
This class of neuromodulator is supplied as a sterile, pre-diluted liquid intended for injection by trained professionals. The toxin acts at cholinergic nerve terminals to reduce neuromuscular activity, enabling precise, localized modulation of targeted areas. Because it is provided as a liquid, no dilution step is required prior to administration in appropriately credentialed settings. Many clinics value the consistency and time savings of an Innotox 50U injection format when standardizing protocols across teams and treatment rooms.
Its liquid state supports uniform unit distribution within the vial. The preparation’s handling profile can help maintain consistent dosing technique, lot to lot, when compared with lyophilized alternatives that require reconstitution. Always follow the manufacturer’s labeling and your clinic’s credentialing, standing orders, and local regulations.
Professional Applications
This product integrates into aesthetic neuromodulator workflows managed by licensed injectors. Teams often incorporate it into standardized mapping approaches and quality-controlled technique checklists. It can support educational programs for staff onboarding and competency maintenance around sterile preparation, injection ergonomics, and documentation.
Clinics building service menus around Botulinum toxin type A 50 Units formats may use this presentation alongside other brands to meet patient preferences and procedural objectives. For broader catalog planning, see our category overview for Botulinum Toxins and review practical guidance in our article Liquid Toxin Guide.
Key Features
- Ready-to-use liquid: eliminates on-site reconstitution and mixing steps.
- Consistent unit allocation: supports predictable draw and dose planning.
- Low-diffusion profile: designed for focused, localized effects under skilled technique.
- Protein-free formula: no human serum albumin or gelatin in the composition.
- Single-vial workflow: simplifies labeling, chain-of-custody, and waste tracking.
- BTX-A 50U vial: clear unit declaration supports inventory controls.
- Stable handling: suitable for standard storage per the manufacturer’s label.
- Sterile manufacturing: produced under quality systems to support clinical use.
Benefits in Practice
The liquid format can shorten room turnover by removing a reconstitution step, reducing variability between providers. It supports consistent viscosity and syringe feel, which many teams find helpful in standardizing technique across injectors and locations. Scheduling becomes more predictable when prep time is defined and repeatable.
Inventory stewardship benefits as well. Unit-level planning is more straightforward when each vial presents the same ready-to-draw format with uniform units. That makes it easier for coordinators to reconcile usage with booked services, and to align purchasing cadence with procedure volumes. For multi-site groups, these attributes help align training, checklists, and supply chain practices across locations.
Composition & Ingredients
Active component: botulinum toxin type A in a sterile, finished liquid formulation suitable for intramuscular use. The composition does not include added stabilizing proteins such as human serum albumin or gelatin. Excipients are present to maintain solution characteristics within labeled specifications. Refer to the manufacturer’s insert for the full qualitative composition and any specific handling advisories.
Packaging & Supply
This presentation is supplied as a single sterile vial containing Botulinum toxin type A 50 Units in a finished solution. The label displays the lot number and expiration date to support traceability in your medical records and inventory systems. Tamper-evident features assist with chain-of-custody integrity from receipt to controlled storage.
SKU: 89639. The vial format supports quick visual verification during pick-and-pack and at the point of use. For clinics evaluating alternate unit counts within the same product line, see the 100U Variant. Many facilities also compare paired alternatives such as Compare Nabota when setting formularies or multi-brand protocols.
Ordering & Logistics
Access is available to licensed clinics and healthcare facilities following account verification. Sign in to view contract tiers and request allocation for scheduled cases. Our logistics team coordinates fulfillment with attention to manufacturer storage guidance, and supports temperature-controlled handling when required and tracked US delivery. Please maintain the product under labeled conditions upon receipt and coordinate internal chain-of-custody to your procedure rooms.
Your team can manage purchasing cycles to align with procedure blocks and staffing. For brand-specific updates and broader catalog planning across this line, visit the Brand Overview page.
Comparable Products
Clinics often evaluate neuromodulators side by side to match technique preferences and program goals. Consider reviewing Compare Xeomin and Explore Dysport to support protocol development and injector training. Cross-brand familiarity can help teams tailor service menus while keeping documentation and inventory controls consistent group-wide.
Pricing & Access
Sign in to view tiered purchasing options for your facility. Contract-based terms may be available for scheduled volumes, multi-site groups, or integrated supply agreements. If your formulary planning includes Innotox 50U wholesale volumes, our account team can align allocations with your forecasted usage and training plans. We provide invoices that reflect lot numbers to support reconciliation with your charting and inventory records.
Availability & Substitutions
Supply can vary by lot and demand. If a specific presentation is unavailable, suitable substitutions within the same class may be considered in coordination with your medical director and injector team. We can assist with cross-referencing alternatives to sustain continuity of care and training schedules. Confirm with your clinical leadership before substituting any neuromodulator in active protocols.
Authoritative Sources
- Medytox – Corporate Information
- NIH MedlinePlus – Botulinum Toxin Injection
- FDA – Botulinum Toxin Products (Class Overview)
To align supply with your clinical schedule, sign in, verify your account, and coordinate allocation for upcoming sessions.
Frequently Asked Questions
Does this product require reconstitution before use?
No. This presentation is supplied as a sterile liquid that arrives ready to draw. Removing the reconstitution step can simplify room turnover and reduce variability tied to mixing technique. Your clinic should still follow aseptic handling, confirm units prior to draw, and maintain documentation of lot and expiry in the patient record. Store and handle the vial according to the manufacturer’s label and your facility’s policies.
How does the diffusion profile compare in practice?
The formulation is engineered for focused, localized action when delivered by trained injectors using appropriate technique. Many clinicians describe the spread characteristics as controlled, which can support precise targeting. Actual performance varies with anatomy, placement, volume per point, and injector technique. Avoid extrapolating across products; align expectations with your protocol training and medical leadership.
What storage and handling considerations apply?
Follow the manufacturer’s labeled storage conditions and handling instructions. The liquid format removes the need for on-site dilution, which can reduce handling steps. Maintain chain-of-custody from receipt through internal storage, and document lot and expiration with each use. If your facility employs environmental monitoring or temperature logs, record storage conditions consistent with policy and applicable regulations.
Is this suitable for clinics transitioning from lyophilized toxins?
Yes. Many facilities adopt this ready-to-use liquid to simplify workflows that previously required reconstitution. Training should address differences in viscosity, draw technique, and unit allocation. Update checklists, labeling, and inventory controls to reflect the liquid format. Conduct competency reviews with injectors before live cases, and compare outcomes against your existing protocols to ensure a smooth transition.
What is included in each vial?
Each vial contains a finished liquid presentation of botulinum toxin type A for intramuscular use. Unit count and identifying information are printed on the manufacturer’s label. The vial includes tamper-evident features and displays lot number and expiration to support traceability. Always verify the label before dispensing and record usage per your facility’s documentation standards.
How can our team integrate it into existing protocols?
Begin by mapping current neuromodulator workflows, then substitute the liquid presentation where reconstitution steps previously existed. Update procedure cards, syringe labeling, and draw volumes according to your medical director’s guidance. Align appointment timing with the shorter prep process, and incorporate the product into staff training and competency checklists. Monitor outcomes, supply usage, and room turnover metrics to validate operational benefits.
Where can we compare it with other neuromodulators?
Many clinics evaluate brands side by side to match injector preferences and service menus. Review class resources and product pages within our catalog to compare handling, format, and packaging. Cross-training on multiple neuromodulators can help maintain scheduling flexibility. If you need assistance assembling a comparative list for your formulary, our account team can provide options from the same therapeutic class.
Specifications
- Main Ingredient: Clostridium Botulinum Toxin Type A
- Manufacturer: German Remedies Private Ltd.
- Drug Class:
- Generic Name: Botulinum Toxin
- Package Contents: 50 U x 1 Vial
- Storage Requirements: Cool Temperature (2℃~8℃)
- Main Usage:
About the Brand
Innotox
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
RejuvaNAD+
Restylane® 1 mL
Related Articles
Lanluma vs Sculptra: Results, Longevity, and Safety
In regenerative aesthetics, collagen biostimulators emerge as leading solutions for natural skin rejuvenation. The global…
Discover Lanluma Injections: The Collagen-Boosting Filler
According to recent market data, the value for collagen-stimulating injectables is estimated to reach USD…
Revitalize Patient Skin with Karisma Injection Technology
In aesthetic medicine, clinicians are continually seeking solutions that enhance skin quality while preserving natural…
Why Elravie Filler Is a Top Choice for Facial Rejuvenation
The demand for advanced and long-lasting dermal fillers continues to grow. According to global market…
Fat Dissolving Injections | Target Stubborn Fat with Ease
Even with the rise of advanced body contouring technologies, fat dissolving injections continue to offer…
Stylage Lip Filler for Clinics: Trusted Aesthetic Results
In today’s world of refined beauty and subtle rejuvenation, patients seek treatments that enhance their…
Sculptra vs Juvederm: Choosing the Best Facial Filler
Facial fillers have become an integral part of modern aesthetic medicine, enabling patients to achieve…
How to Get Rid of Fine Lines and Restore Youthful Radiance
Fine lines are among the earliest visible signs of aging, appearing subtly before progressing into…

